Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Expert Review of Molecular Diagnostics

• Publication date

  2016-01-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/14737159.2016.1132164PMID 26652067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer

  2018cited by this paper
• Circulating cell‐free high mobility group AT‐hook 2 mRNA as a detection marker in the serum of colorectal cancer patients

  2018cited by this paper
• Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing.

  2017cited by this paper
• Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluation

  2017cited by this paper
• Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples

  2017cited by this paper
• Cell-free DNA levels and correlation to stage and outcome following treatment of locally advanced rectal cancer

  2017cited by this paper
• Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients

  2017cited by this paper
• Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

  2017cited by this paper
• MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis

  2017cited by this paper
• LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer—Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result

  2017cited by this paper
• Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature

  2017cited by this paper
• Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer

  2017cited by this paper
• DNA methylation and DNA methyltransferases

  2017cited by this paper
• The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review

  2017cited by this paper
• Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?

  2017cited by this paper
• Tumor‐associated DNA mutation detection in individuals undergoing colonoscopy

  2017cited by this paper
• LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer

  2017cited by this paper
• Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing

  2017cited by this paper
• Long non-coding RNA growth arrest specific transcript 5 acts as a tumour suppressor in colorectal cancer by inhibiting interleukin-10 and vascular endothelial growth factor expression

  2017cited by this paper
• Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer

  2017cited by this paper
• Diagnostic and prognostic role of cell‐free DNA testing for colorectal cancer patients

  2017cited by this paper
• MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2

  2017cited by this paper
• Progress on the clinical application of the SEPT9 gene methylation assay in the past 5 years.

  2017cited by this paper
• Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression

  2017cited by this paper
• Hypermethylated DNA, a circulating biomarker for colorectal cancer detection

  2017cited by this paper
• Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients

  2017cited by this paper
• Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer

  2017cited by this paper
• Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens

  2017cited by this paper
• A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.

  2017cited by this paper
• Liquid biopsies come of age: towards implementation of circulating tumour DNA

  2017cited by this paper
• LncRNA‐ATB mediated E‐cadherin repression promotes the progression of colon cancer and predicts poor prognosis

  2016cited by this paper
• A Pilot Study of CK19, CK20 and GCC mRNA in the Peripheral Blood as a Colorectal Cancer Biomarker Panel

  2016cited by this paper
• A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit

  2016cited by this paper
• FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.

  2016cited by this paper
• HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor

  2016cited by this paper
• Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract

  2016cited by this paper
• Circulating long non-coding RNAs in cancer: current status and future perspectives

  2016cited by this paper
• Features of Circulating DNA Fragmentation in Blood of Healthy Females and Breast Cancer Patients.

  2016cited by this paper
• Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection

  2016cited by this paper
• Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls

  2016cited by this paper
• Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial–mesenchymal transition

  2016cited by this paper
• Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care

  2016cited by this paper
• Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAs

  2016cited by this paper
• Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer

  2016cited by this paper
• The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics.

  2016cited by this paper
• Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.

  2016cited by this paper
• Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer

  2016cited by this paper
• Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases

  2016cited by this paper
• The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA

  2016cited by this paper
• Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells

  2016cited by this paper
• Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma

  2015cited by this paper
• Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

  2015cited by this paper
• Role of Circulating Cell-Free DNA in Cancers

  2015cited by this paper
• A plasma microRNA panel for early detection of colorectal cancer

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Clinical significance of urothelial carcinoma associated 1 in colon cancer.

  2015cited by this paper
• Focal Colonic FDG Activity with PET/CT: Guidelines for Recommendation of Colonoscopy

  2015cited by this paper
• Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.

  2015cited by this paper
• Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma

  2015cited by this paper
• SALL4 as a new biomarker for early colorectal cancers

  2015cited by this paper
• Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer

  2015cited by this paper
• Circulating lncRNAs associated with occurrence of colorectal cancer progression.

  2015cited by this paper
• Plasma methylated septin 9: a colorectal cancer screening marker

  2015cited by this paper
• Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.

  2015cited by this paper
• Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.

  2015cited by this paper
• Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia

  2015cited by this paper
• Diagnostic miss rate for colorectal cancer: an audit

  2015cited by this paper
• Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death

  2015cited by this paper
• The Path to Cancer --Three Strikes and You're Out.

  2015cited by this paper
• Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.

  2015cited by this paper
• Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer.

  2015cited by this paper
• Performance of a second‐generation methylated SEPT9 test in detecting colorectal neoplasm

  2015cited by this paper
• Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer.

  2015cited by this paper
• Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assay.

  2014cited by this paper
• Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

  2014cited by this paper
• Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer

  2014cited by this paper
• Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens

  2014cited by this paper
• Plasma Bmi1 mRNA as a potential prognostic biomarker for distant metastasis in colorectal cancer patients.

  2014cited by this paper
• Multitarget stool DNA testing for colorectal-cancer screening.

  2014cited by this paper
• Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer.

  2014cited by this paper
• CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia

  2014cited by this paper
• Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer

  2014cited by this paper
• Circulating Free DNA in a Screening Program for Early Colorectal Cancer Detection

  2014cited by this paper
• Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer

  2014cited by this paper
• Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT.

  2014cited by this paper
• Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer

  2014cited by this paper
• Comparison of the accuracy of CT colonography and colonoscopy in the diagnosis of colorectal cancer

  2014cited by this paper
• Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.

  2014cited by this paper
• Liquid biopsies: genotyping circulating tumor DNA.

  2014cited by this paper
• Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT)

  2014cited by this paper
• Circulating Exosomal microRNAs as Biomarkers of Colon Cancer

  2014cited by this paper
• Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer

  2014cited by this paper
• Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study

  2014cited by this paper
• Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system.

  2014cited by this paper
• HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.

  2014cited by this paper
• Direct Serum Assay for Cell-Free Bmi-1 mRNA and Its Potential Diagnostic and Prognostic Value for Colorectal Cancer

  2014cited by this paper
• Advances in the medical research and clinical applications on the plasma DNA.

  2014cited by this paper
• Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection

  2014cited by this paper

• Clinical relevance of plasma-derived exosomal long non-coding RNAs (lncRNAs) CCAT1 and XIST in colorectal cancer patients

  2025cites this paper
• Liquid biopsy for the management of gastrointestinal cancers.

  2025cites this paper
• Engineering Lanthanide Ion-Labeled Aptamers for ICP-MS Profiling of Serum-Derived Extracellular Vesicles from Colorectal Cancer

  2025cites this paper
• Single-molecule immunoassay technology: Recent advances.

  2023cites this paper
• Liquid biopsy in colorectal cancer: onward and upward.

  2023cites this paper
• Versatile Dynamic Bioactive Lubricant-Infused Surface for Effective Isolation of Circulating Tumor Cells.

  2023cites this paper
• Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?

  2022cites this paper
• Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay

  2020cites this paper
• Automated molecular-image cytometry and analysis in modern oncology

  2020cites this paper
• A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.

  2020cites this paper
• Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature

  2020cites this paper
• Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis

  2020cites this paper
• [Characteristics and diagnostic applications of circulating cell-free DNA in colorectal cancer].

  2019influential citation
• Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine

  2019cites this paper
• Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection

  2019cites this paper
• State of the Art and Future Direction for the Analysis of Cell-Free Circulating DNA

  2019cites this paper
• Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update

  2019cites this paper
• Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors

  2019cites this paper
• Tumor-derived extracellular vesicles and microRNAs: Functional roles, diagnostic, prognostic and therapeutic options.

  2019cites this paper
• Precision medicine for gastrointestinal cancer: Recent progress and future perspective

  2019cites this paper
• Liquid biopsies in gastrointestinal malignancies: when is the big day?

  2018cites this paper
• [In vivo analysis of circulating cell-free DNA release and degradation].

  2018cites this paper
• A sejten kívüli szabad DNS felszabadulásának és degradációjának in vivo elemzése

  2018cites this paper
• DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies

  2018cites this paper
• Review of Blood-Based Colorectal Cancer Screening : How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation ?

  2018cites this paper
• Review of Blood‐Based Colorectal Cancer Screening: How Far Are Circulating Cell‐Free DNA Methylation Markers From Clinical Implementation?

  2018cites this paper
• Tissue Versus Liquid Biopsy: Opposite or Complementary?

  2017cites this paper
• Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer1

  2017cites this paper
• International scientific communications in the field of colorectal tumour markers

  2017cites this paper
• Diagnostic value of long noncoding RNAs for hepatocellular carcinoma

  2017cites this paper
• Advances in Circulating Tumor DNA Analysis.

  2017cites this paper
• Screening for Colorectal Cancer Based on the Promoter Methylation Status of the Septin 9 gene in Plasma Cell Free DNA

  2017cites this paper
• Personalització del cribratge del càncer colorectal

  2017cites this paper
• Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer1

  2016influential citation
• Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine.

  2016cites this paper
• Neueste technologische Entwicklungen für die Analyse von zirkulierender Tumor-DNA

  2016cites this paper